Differentially expressed gene products in glioblastoma cells suppressed for tumorigenicity.
暂无分享,去创建一个
W. Yung | A. Ligon | P. Steck | M. Pershouse | S. Jasser | Y. K. Hong
[1] Jan Mollenhauer,et al. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3–26.1 is deleted in malignant brain tumours , 1997, Nature Genetics.
[2] M. Wigler,et al. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[3] W. K. Alfred Yung,et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.
[4] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[5] A. Ligon,et al. Identification of a novel gene product, RIG, that is down-regulated in human glioblastoma , 1997, Oncogene.
[6] T. Mikkelsen,et al. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. , 1996, Cancer research.
[7] R. McLendon,et al. Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. , 1995, Oncogene.
[8] A. Ligon,et al. Two tumor suppressive loci on chromosome 10 involved in human glioblastomas , 1995, Genes, chromosomes & cancer.
[9] V. Ganju,et al. Region‐specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma , 1995, Genes, chromosomes & cancer.
[10] S. Benkovic,et al. Isoforms of ferritin have a specific cellular distribution in the brain , 1994, Journal of neuroscience research.
[11] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[12] E Stubblefield,et al. Analysis of the functional role of chromosome 10 loss in human glioblastomas. , 1993, Cancer research.
[13] D. Fults,et al. Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme , 1993, Genes, chromosomes & cancer.
[14] C. Deber,et al. The structure and function of central nervous system myelin. , 1993, Critical reviews in clinical laboratory sciences.
[15] D. Fults,et al. Chromosome 11p15 deletions in human malignant astrocytomas and primitive neuroectodermal tumors. , 1992, Genomics.
[16] M. Pershouse,et al. Direct formation of microcells from mitotic cells for use in chromosome transfer , 1992, Somatic cell and molecular genetics.
[17] B. Scheithauer,et al. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas , 1992, Genes, chromosomes & cancer.
[18] James M. Sikela,et al. Single pass sequencing and physical and genetic mapping of human brain cDNAs , 1992, Nature Genetics.
[19] W. J. Brammar,et al. Differential expression of the mitochondrial gene cytochrome oxidase ii in benign and malignant breast tissue , 1992, The Journal of pathology.
[20] I. Petersen,et al. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. , 1992, Journal of neurosurgery.
[21] A. Friedman,et al. Loss of heterozygosity for 10q loci in human gliomas , 1992, Genes, chromosomes & cancer.
[22] V. P. Collins,et al. Chromosome 9 deletion mapping reveals interferon alpha and interferon beta-1 gene deletions in human glial tumors. , 1991, Cancer research.
[23] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[24] R. White,et al. Allelotype of human malignant astrocytoma. , 1990, Cancer research.
[25] D. Bigner,et al. Cytogenetics of human brain tumors. , 1990, Cancer genetics and cytogenetics.
[26] Y. Nakamura,et al. Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma. , 1989, Cancer research.
[27] W. Richardson,et al. PDGF A chain homodimers drive proliferation of bipotential (O‐2A) glial progenitor cells in the developing rat optic nerve. , 1989, The EMBO journal.
[28] V. Chan,et al. Imbalance of purine nucleotides in alanosine-resistant baby hamster kidney cells , 1989, Somatic cell and molecular genetics.
[29] W. Yung,et al. Modulation of growth and epidermal growth factor receptor activity by retinoic acid in human glioma cells. , 1989, Cancer research.
[30] Teri,et al. Molecular Cloning A Laboratory Manual Second Edition Sambrook , 1989 .
[31] C. James,et al. Clonal genomic alterations in glioma malignancy stages. , 1988, Cancer research.
[32] C. Heldin,et al. A glioma-derived PDGF a chain homodimer has different functional activities from a PDGF AB heterodimer purified from human platelets , 1988, Cell.
[33] D. Bigner,et al. Specific chromosomal abnormalities in malignant human gliomas. , 1988, Cancer research.
[34] K. Kinzler,et al. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[35] A. Feinberg,et al. "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum. , 1984, Analytical biochemistry.
[36] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[37] A. Feinberg,et al. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.
[38] M. Raff,et al. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium , 1983, Nature.
[39] W. Rutter,et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.
[40] H. Varmus,et al. Purification of DNA complementary to nucleotide sequences required for neoplastic transformation of fibroblasts by avian sarcoma viruses. , 1976, Journal of molecular biology.
[41] P. Leder,et al. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. , 1972, Proceedings of the National Academy of Sciences of the United States of America.